doi: 10.1038/s41591-022-02026-4 Summary Keywords obesity, molecular mechanism, semaglutide, liraglutide, weight loss Citation Tamayo-Trujillo R, Ruiz-Pozo VA, Cadena-Ullauri S, Guevara-Ramrez P, Paz-Cruz E, Zambrano-Villacres R, Simancas-Racines D and Zambrano AK (2024) Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity
Almost 5% reported a loss of appetite
Because GLP-1 medications often lead to rapid and significant weight loss, it's possible that any hair thinning experienced is a result of telogen effluvium, rather than a direct side effect of the drug itself
Une tude publie dans l' American Journal of Respiratory and Critical Care Medicine (1997) a montr que le glutathion nbulis provoquait une bronchoconstriction significative chez des patients souffrant d'asthme lger, avec une diminution du VEMS de 11 % par rapport au placebo